What is Tenon Medical Inc?
, a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.
TNON · Verdict
Solid reward · elevated risk
TNON stands out on growth and balance sheet, but watch the cash flow signal.
Based on 88% data coverage
TNON · Verdict
Rev +173.6% CAGR · earnings +24.7%
Current ratio 4.39
Above average
-307% free-cash-flow margin
-417% net margin · -335% ROE
Below average
Model-based scoring. For information only — not financial advice.
, a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 10.15M, and a P/E ratio of 0.2x.
The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.